La maladie de Parkinson en France (serveur d'exploration) - Exploration (Accueil)

Index « Keywords » - entrée « Dose-Response Relationship, Drug »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Dose activity relation < Dose-Response Relationship, Drug < Dose-Response Relationship, Radiation  Facettes :

List of bibliographic references indexed by Dose-Response Relationship, Drug

Number of relevant bibliographic references: 61.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000127 (2016) Sandra Dovero [France] ; Christian Gross [France] ; Erwan Bezard [France]Unexpected toxicity of very low dose MPTP in mice: A clue to the etiology of Parkinson's disease?
000271 (2016) Mathieu Schmitt [Belgique] ; Benjamin Dehay [France] ; Erwan Bezard [France] ; F Javier Garcia-Ladona [Belgique]Harnessing the trophic and modulatory potential of statins in a dopaminergic cell line.
000315 (2016) Clément François [États-Unis] ; Robert A. Hauser [États-Unis] ; Samuel Aballéa [France] ; Julie Dorey [États-Unis] ; Elizaveta Kharitonova [France] ; L Arthur Hewitt [États-Unis]Cost-effectiveness of droxidopa in patients with neurogenic orthostatic hypotension: post-hoc economic analysis of Phase 3 clinical trial data.
000535 (2015) Robert A. Hauser [États-Unis] ; Fabrizio Stocchi [Italie] ; Olivier Rascol [France] ; Susan B. Huyck [États-Unis] ; Rachel Capece [États-Unis] ; Tony W. Ho [États-Unis] ; Peter Sklar [États-Unis] ; Christopher Lines [États-Unis] ; David Michelson [États-Unis] ; David Hewitt [États-Unis]Preladenant as an Adjunctive Therapy With Levodopa in Parkinson Disease: Two Randomized Clinical Trials and Lessons Learned.
000623 (2015) Hyung-Wook Kim [États-Unis, Corée du Sud] ; Won-Seok Choi [États-Unis, Corée du Sud] ; Noah Sorscher [États-Unis] ; Hyung Joon Park [Corée du Sud] ; François Tronche [France] ; Richard D. Palmiter [États-Unis] ; Zhengui Xia [États-Unis]Genetic reduction of mitochondrial complex I function does not lead to loss of dopamine neurons in vivo
000A22 (2014) Carole Hyacinthe [France] ; Quentin Barraud [France] ; François Tison [France] ; Erwan Bezard [République populaire de Chine] ; Imad Ghorayeb [France]D1 receptor agonist improves sleep-wake parameters in experimental parkinsonism.
000A28 (2014) Wai Kin D. Ko [France] ; Elsa Pioli ; Qin Li ; Steve Mcguire ; Audrey Dufour ; Todd B. Sherer ; Erwan Bezard ; Maurizio F. FacherisCombined fenobam and amantadine treatment promotes robust antidyskinetic effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned primate model of Parkinson's disease.
000C23 (2013) Khaled-Ezaheir Bennouar [France] ; Michelle A. Uberti ; Christophe Melon ; Maria D. Bacolod ; Hermogenes N. Jimenez ; Manuel Cajina ; Lydia Kerkerian-Le Goff ; Darío Doller ; Paolo GubelliniSynergy between L-DOPA and a novel positive allosteric modulator of metabotropic glutamate receptor 4: implications for Parkinson's disease treatment and dyskinesia.
000C99 (2013) Jonathan Chetrit [France] ; Anne Taupignon ; Lionel Froux ; Stephanie Morin ; Rabia Bouali-Benazzouz ; Frédéric Naudet ; Nabila Kadiri ; Christian E. Gross ; Bernard Bioulac ; Abdelhamid BenazzouzInhibiting subthalamic D5 receptor constitutive activity alleviates abnormal electrical activity and reverses motor impairment in a rat model of Parkinson's disease.
000E76 (2013) Suzanne Lesage [France] ; Mathieu Anheim [France] ; Franck Letournel ; Luc Bousset ; Aurélie Honoré [France] ; Nelly Rozas [France] ; Laura Pieri ; Karine Madiona ; Alexandra Dürr [France] ; Ronald Melki ; Christophe Verny [France] ; Alexis Brice [France]G51D α‐synuclein mutation causes a novel Parkinsonian–pyramidal syndrome
001045 (2012) N. Carrière [France] ; A. Kreisler ; K. Dujardin ; A. Destée ; L. Defebvre[Impulse control disorders in Parkinson's disease: A cohort of 35 patients].
001293 (2012) Bruno Dubois [France] ; Eduardo Tolosa [Espagne] ; Regina Katzenschlager [Autriche] ; Murat Emre [Turquie] ; Andrew J. Lees [Royaume-Uni] ; Günther Schumann [Allemagne] ; Emmanuelle Pourcher [Canada] ; Julian Gray [Suisse] ; Gail Thomas [Royaume-Uni] ; Jina Swartz [Royaume-Uni] ; Timothy Hsu [États-Unis] ; Margaret L. Moline [États-Unis]Donepezil in Parkinson's disease dementia: A randomized, double‐blind efficacy and safety study
001B60 (2010) Olivier Rascol [France] ; Jean-Philippe Azulay [France] ; Olivier Blin [France] ; Anne-Marie Bonnet [France] ; Christine Brefel-Courbon [France] ; Pierre Césaro [France] ; Philippe Damier [France] ; Bérengère Debilly [France] ; Frank Durif [France] ; Monique Galitzky [France] ; Jean-Marie Grouin [France] ; Sylvie Pennaforte [France] ; Gabriel Villafane [France] ; Sadek Yaici [France] ; Yves Agid [France]Orodispersible sublingual piribedil to abort OFF episodes: A single dose placebo‐controlled, randomized, double‐blind, cross‐over study
001C04 (2010) Olivier Rascol [France] ; Paolo Barone [Italie] ; Robert A. Hauser [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Anthony H. V. Schapira [Royaume-Uni] ; Laurence Salin [France] ; Mandy Sohr [Allemagne] ; Catherine Debieuvre [France]Efficacy, safety, and tolerability of overnight switching from immediate‐ to once daily extended‐release pramipexole in early Parkinson's disease
001E58 (2009) Serena Santucci [France] ; Nicole Zsürger ; Joëlle Chabrybeta-N-methylamino-L-alanine induced in vivo retinal cell death.
001E89 (2009) Olivier Rascol [France] ; Santiago Perez-LloretRotigotine transdermal delivery for the treatment of Parkinson's disease.
001F11 (2009) Dario Cuomo [France] ; Giuseppina Martella ; Emanuela Barabino ; Paola Platania ; Daniela Vita ; Graziella Madeo ; Chelliah Selvam ; Cyril Goudet ; Nadia Oueslati ; Jean-Philippe Pin ; Francine Acher ; Antonio Pisani ; Corinne Beurrier ; Christophe Melon ; Lydia Kerkerian-Le Goff ; Paolo GubelliniMetabotropic glutamate receptor subtype 4 selectively modulates both glutamate and GABA transmission in the striatum: implications for Parkinson's disease treatment.
001F38 (2009) Emmanuel Itti [France] ; Gabriel Villafane ; Zoulikha Malek ; Pierre Brugières ; Daniela Capacchione ; Laurent Itti ; Patrick Maison ; Pierre Cesaro ; Michel MeignanDopamine transporter imaging under high-dose transdermal nicotine therapy in Parkinson's disease: an observational study.
001F55 (2009) Hélène Gervais-Bernard [France] ; Jing Xie-Brustolin ; Patrick Mertens ; Gustavo Polo ; Hélène Klinger ; Dario Adamec ; Emmanuel Broussolle ; Stéphane ThoboisBilateral subthalamic nucleus stimulation in advanced Parkinson's disease: five year follow-up.
002264 (2008) J-P Azulay [France] ; F. Durif ; R. Rogez ; C. Tranchant ; I. Bourdeix ; K. Rerat[Precoce survey: a new self-assessment patient card for early detection and management of Parkinson disease fluctuations].
002278 (2008) Olivier Rascol [France] ; Werner Poewe [Autriche] ; Andrew Lees ; Marina Aristin ; Laurence Salin ; Nolwenn Juhel ; Lisa Waldhauser ; Thomas SchindlerTesofensine (NS 2330), a monoamine reuptake inhibitor, in patients with advanced Parkinson disease and motor fluctuations: the ADVANS Study.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Dose-Response Relationship, Drug" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Dose-Response Relationship, Drug" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Dose-Response Relationship, Drug
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024